8 Results for "

SUDHL5

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "SUDHL5" in MCE Product Catalog:

Cat. No.: HY-169244
CAS No.: 3008612-35-6
Target:  

CDK Bcl-2 Family

Research Areas:  

Cancer

CDK-TCIP1 is a bivalent molecule linking CDK9 inhibitor SNS-032 (HY-10008) to BCL6 ligand BI3812 (HY-111381). CDK-TCIP1 potently and specifically kills BCL6-overexpressing cells with EC50 of 7.7 nM for SUDHL5 cells .
loading...
    loading...
Cat. No.: HY-156437
CAS No.: 2225902-98-5
Purity:  99.73%
Target:  

Apoptosis NEKs Mitosis Akt

Research Areas:  

Cancer

NBI-961 is a NEK2 catalytic inhibitor with human NEK2 IC50 ~12-fold lower than FLT3. NBI-961 induces proteasomal degradation of NEK2. NBI-961 induces G2/mitosis arrest, apoptosis, and compromises viability in DLBCL cells and patient-derived cells. NBI-961 sensitizes DLBCL cells to doxorubicin and vincristine, and suppresses DLBCL tumor growth in mice. NBI-961 can be used for the research of diffuse large b cell lymphoma .
loading...
    loading...
Cat. No.: HY-161828
CAS No.: 3103763-70-5
Target:  

PROTACs CDK

Research Areas:  

Cancer

JWZ-5-13 is a CDK7 PROTAC degrader. JWZ-5-13 inhibits the proliferation of cancer cells. JWZ-5-13 is applicable to the research of ovarian cancer, diffuse large B-cell lymphoma, acute T-lymphoblastic leukemia and non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-173552
CAS No.: 3067681-36-8
Synonyms: KAT-TCIP
Research Areas:  

Cancer

TCIP3 is a bivalent molecular glue degrader that binds dually to p300/CBP and BCL6. TCIP3 redirects p300 and CBP, thereby activating programmed cell death genes that are normally repressed by the oncogenic driver gene BCL6. TCIP3 induces acetylation of BCL6 and histone tails, inhibits c-MYC transcription. TCIP3 can be used for the research of diffuse large B-cell lymphoma (DLBCL) .
loading...
    loading...
Cat. No.: HY-169245
Target:  

CDK BCL6

Research Areas:  

Cancer

DK-TCIP2, linking inhibitor of CDK9 SNS-032 (HY-10008) with ligands of BCL6 BI-3812 (HY-111381), is a anticancer agent. DK-TCIP2 shows anticancer activity in vivo and in vitro and can be used for study of lymphoma cancer .
loading...
    loading...
Cat. No.: HY-170762
CAS No.: 2155856-87-2
Target:  

Apoptosis Bcl-2 Family

Research Areas:  

Cancer

Mcl-1 inhibitor 21 (Example 1-36) is a Mcl-1 inhibitor with an IC50 of 328 nM. Mcl-1 inhibitor 21 exhibits proapototic and anti-proliferation activities against SUDHL5 and SUDHL10 cell lines and can be utilized in cancer research .
loading...
    loading...
Cat. No.: HY-170762A
CAS No.: 2157421-23-1
Target:  

Apoptosis Bcl-2 Family

Research Areas:  

Cancer

(+)-Mcl-1 inhibitor 21 (Example 1-37) is a Mcl-1 inhibitor with an IC50 of 172 nM. (+)-Mcl-1 inhibitor 21 exhibits proapototic and anti-proliferation activities against SUDHL5 and SUDHL10 cell lines and can be utilized in cancer research .
loading...
    loading...
Cat. No.: HY-170762B
CAS No.: 2157421-24-2
Target:  

Apoptosis Bcl-2 Family

Research Areas:  

Cancer

(-)-Mcl-1 inhibitor 21 (Example 1-38) is a Mcl-1 inhibitor with an IC50 of 7.51 μM. (-)-Mcl-1 inhibitor 21 exhibits proapototic and anti-proliferation activities against SUDHL5 and SUDHL10 cell lines and can be utilized in cancer research .
loading...
    loading...